ANVS

Annovis Bio, Inc.

Latest Form 4:Purchase$143KbyHoffman Michael B (Director) · filed May 22, 2026

Annovis Bio, Inc. (ANVS) has 3 SEC Form 4 filings (6 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 22, 2026.

The most active filer is Director Hoffman Michael B with 3 filings. Insiders have net bought $1.8M over the trailing 6 months. The largest single insider purchase in this window was $1.5M by Director Hoffman Michael B on Apr 2, 2026.

  • Industry:Biotechnology
  • CEO:Maria L. Maccecchini
  • Employees:8
  • HQ:Malvern, PA, US
  • IPO:2020-01-29

Insider Buying

$1.8M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$64.1M

latest known value

Source
Purchase$143KMay 22SEC ↗
Hoffman Michael BFirst in 4 months
Purchase$1.5MApr 3SEC ↗
Hoffman Michael BFirst filing
Purchase$194KDec 8SEC ↗

Related companies

Annovis Bio, Inc. is in the Healthcare sector.